↓ Skip to main content

Dove Medical Press

Article Metrics

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Overview of attention for article published in Clinical Interventions in Aging, November 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
21 Mendeley
Title
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Published in
Clinical Interventions in Aging, November 2009
DOI 10.2147/cia.s8367
Pubmed ID
Authors

Dimitrios Karagiannis

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 19%
Other 3 14%
Student > Bachelor 3 14%
Student > Postgraduate 3 14%
Student > Ph. D. Student 2 10%
Other 5 24%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 14 67%
Agricultural and Biological Sciences 2 10%
Unspecified 1 5%
Nursing and Health Professions 1 5%
Physics and Astronomy 1 5%
Other 1 5%
Unknown 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2018.
All research outputs
#5,609,976
of 17,366,233 outputs
Outputs from Clinical Interventions in Aging
#631
of 1,598 outputs
Outputs of similar age
#135,269
of 374,859 outputs
Outputs of similar age from Clinical Interventions in Aging
#22
of 50 outputs
Altmetric has tracked 17,366,233 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,598 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,859 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.